Ensign Peak Advisors
MEDP icon

Ensign Peak Advisors’s Medpace MEDP Stock Holding History

Ensign Peak Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.8M Sell
16,625
-12,425
-43% -$5.73M 0.01% 460
2026
Q1 		$13.9M Sell
29,050
-1,441
-5% -$738K 0.03% 361
2025
Q4 		$17.1M Buy
30,491
+9,273
+44% +$5.26M 0.03% 310
2025
Q3 		$10.9M Sell
21,218
-20,505
-49% -$8.95M 0.02% 437
2025
Q2 		$13.1M Buy
41,723
+8,318
+25% +$2.5M 0.02% 409
2025
Q1 		$10.2M Sell
33,405
-17,043
-34% -$5.73M 0.02% 460
2024
Q4 		$16.8M Buy
50,448
+15,036
+42% +$5.1M 0.03% 345
2024
Q3 		$11.8M Sell
35,412
-411
-1% -$156K 0.02% 424
2024
Q2 		$14.8M Buy
35,823
+22,441
+168% +$8.89M 0.03% 367
2024
Q1 		$5.41M Buy
13,382
+4,467
+50% +$1.57M 0.01% 613
2023
Q4 		$2.73M Buy
8,915
+180
+2% +$48.6K 0.01% 798
2023
Q3 		$2.12M Buy
8,735
+265
+3% +$67.8K ﹤0.01% 822
2023
Q2 		$2.03M Buy
8,470
+1,490
+21% +$310K ﹤0.01% 871
2023
Q1 		$1.31M Buy
6,980
+150
+2% +$31K ﹤0.01% 1030
2022
Q4 		$1.45M Sell
6,830
-1,100
-14% -$220K ﹤0.01% 935
2022
Q3 		$1.25M Sell
7,930
-1,660
-17% -$265K ﹤0.01% 960
2022
Q2 		$1.44M Hold
9,590
– – ﹤0.01% 949
2022
Q1 		$1.57M Sell
9,590
-1,545
-14% -$255K ﹤0.01% 980
2021
Q4 		$2.42M Sell
11,135
-17,865
-62% -$3.74M ﹤0.01% 891
2021
Q3 		$5.49M Hold
29,000
– – 0.01% 619
2021
Q2 		$5.12M Buy
29,000
+6,100
+27% +$1.05M 0.01% 642
2021
Q1 		$3.76M Hold
22,900
– – 0.01% 758
2020
Q4 		$3.19M Sell
22,900
-600
-3% -$75.6K 0.01% 802
2020
Q3 		$2.63M Hold
23,500
– – 0.01% 829
2020
Q2 		$2.19M Hold
23,500
– – 0.01% 922
2020
Q1 		$1.72M Hold
23,500
– – 0.01% 913
2019
Q4 		$1.98M Buy
+23,500
New +$1.82M 0.01% 1066

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Ensign Peak Advisors's MEDP Position: Q2 2026 in Review

Ensign Peak Advisors reduced its Medpace (MEDP) stake by 43% in Q2 2026, selling an estimated $5.73M and leaving 16,625 shares worth $8.8M. The position accounts for 0.01% of the portfolio, ranked #460.

Ensign Peak Advisors first reported a position in MEDP in Q4 2019 and has held it in 27 quarters since. The position peaked at $17.1M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Ensign Peak Advisors held 16,625 shares of Medpace worth $8.8M as of Q2 2026.
  • Ensign Peak Advisors sold 12,425 Medpace shares in Q2 2026, an estimated $5.73M.
  • Medpace made up 0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #460 holding.
  • Ensign Peak Advisors first reported a position in Medpace in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Medpace position peaked at $17.1M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.